Gan & Lee Pharmaceuticals Co Ltd (603087) — Capital Reinvestment Ratio

Latest as of September 2025: 1.01x

Gan & Lee Pharmaceuticals Co Ltd (603087) has a Capital Reinvestment Ratio of 1.01x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥257.27 Million) in capital expenditures (CN¥260.89 Million). Check Gan & Lee Pharmaceuticals Co Ltd (603087) tangible equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

1.01x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥257.27 Million
CNY

Capital Expenditures

CN¥260.89 Million
CNY

Data as of

Sep 2025
Most recent filing

Gan & Lee Pharmaceuticals Co Ltd Capital Reinvestment Ratio (2013–2025)

This chart tracks Gan & Lee Pharmaceuticals Co Ltd's Capital Reinvestment Ratio across 13 annual periods. For the full cash flow conversion analysis, see 603087 cash generation efficiency.

Annual Capital Reinvestment Ratio for Gan & Lee Pharmaceuticals Co Ltd (2013–2025)

Year-by-year Capital Reinvestment Ratio for Gan & Lee Pharmaceuticals Co Ltd from 2013 to 2025. See Gan & Lee Pharmaceuticals Co Ltd (603087) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2025 1.18x CN¥784.28 Million CN¥926.09 Million ▲ +43.9%
2024 0.82x CN¥537.31 Million CN¥440.80 Million ▼ -36.6%
2023 1.29x CN¥427.69 Million CN¥553.06 Million ▼ -61.0%
2022 3.31x CN¥296.68 Million CN¥983.44 Million ▲ +416.4%
2021 0.64x CN¥1.08 Billion CN¥692.08 Million ▲ +36.9%
2020 0.47x CN¥1.24 Billion CN¥582.14 Million ▲ +33.1%
2019 0.35x CN¥1.15 Billion CN¥406.63 Million ▼ -71.3%
2018 1.23x CN¥418.04 Million CN¥513.44 Million ▲ +170.6%
2017 0.45x CN¥949.60 Million CN¥431.02 Million ▲ +35.2%
2016 0.34x CN¥769.63 Million CN¥258.48 Million ▼ -59.2%
2015 0.82x CN¥447.42 Million CN¥368.43 Million ▼ -20.3%
2014 1.03x CN¥305.22 Million CN¥315.47 Million ▲ +111.5%
2013 0.49x CN¥204.73 Million CN¥100.06 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow